Form 4 for KNSA Kiniksa Pharmaceuticals International, plc
Accepted 2025-06-05 00:00:00 ET · period of report 2025-06-03 · accession 0001415889-25-015782 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2025-06-05 | 2025-06-03 | KNSA | Megna Michael R | CAO | M - OptEx | $15.50 | +15.2K | 47.8K | +47% | +$235.8K |
| D | 2025-06-05 | 2025-06-03 | KNSA | Megna Michael R | CAO | S - Sale+OE | $28.75 | -15.2K | 32.5K | -32% | -$437.3K |
| D | 2025-06-05 | 2025-06-03 | KNSA | Megna Michael R | CAO | M - OptEx | $0.00 | -15.2K | 791 | -95% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Class A Ordinary Share | 2025-06-03 | M | A | 15,211 | $15.50 | 47,757 | D | — | — | |
| 2 | Common | Class A Ordinary Share | 2025-06-03 | S | D | 15,211 | $28.75 | 32,546 | D | — | — | (F2) This transaction was executed in multiple trades through a broker-dealer at prices ranging between $28.75 and $28.755. The price reported in this column reflects a weighted average sales price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of Shares sold at each price. |
| 3 | Derivative | Share Option | 2025-06-03 | M | D | 15,211 | $0.00 | 791 | D | $15.50 · — to 2030-09-09 | 15,211 Class A Ordinary Share | (F3) The option is fully vested and exercisable. |